VCON yields 3.08% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, VCON + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VCON + PFE for your $10,000?
Vicon Industries, Inc. designs, develops, assembles, and markets video management systems and system components for use in security, surveillance, safety, and communication applications worldwide. Its product line comprises various video and access control system elements, including cameras for image capture and stand-alone network video management system software, as well as various video recording, storage, management, output devices, and door controllers and peripherals; analog, digital, and high definition megapixel cameras for fixed and robotic positioning applications; and other video system components, such as video encoders decoders and monitors, camera lenses, housings and mounts, matrix video switchers and controls, and various video transmission devices. The company's access control system comprises electronic door controllers and communication panels, which is managed by network access control software. Its products are used by commercial and industrial users comprising office buildings, manufacturing plants, warehouses, apartment complexes, shopping malls, and retail stores; federal, state, and local governments for national security purposes, agency facilities, prisons, and military installations; and financial institutions that include banks, clearing houses, brokerage firms, and depositories for security purposes. The company's products are also used by transportation departments for highway traffic control, and bridge and tunnel monitoring, as well as airport, subway, bus, and seaport security and surveillance; gaming casinos; health care facilities, which comprise hospitals; and institutions of education, such as schools and universities, as well as hotels and sports arenas. It sells its products primarily to independent dealers, system integrators, and security products distributors. The company was founded in 1967 and is headquartered in Hauppauge, New York.
Full VCON Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.